Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Archiv Der Pharmazie
|
June 15, 2021
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor
Sarah H M Khairat, Mohamed A Omar, Fatma A F Ragab, et al.
Reumatologia Clinica
|
June 20, 2021
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters
Abeer M Ghandour, Rania M Gamal, Gehan Seif Eldein, et al.
European Journal of Medicinal Chemistry
|
February 3, 2023
Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore
Han Wee Ong, Anna Truong, Frank Kwarcinski, et al.
Reumatologia Clinica
|
November 26, 2022
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters
Abeer M Ghandour, Rania M Gamal, Gehan Seif Eldein, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates
Shadia A Galal, Muhammad Khattab, Samia A Shouman, et al.
The Plant Journal : for Cell and Molecular Biology
|
September 25, 2016
Pre-mRNA splicing repression triggers abiotic stress signaling in plants
Yu Ling, Sahar Alshareef, Haroon Butt, et al.
Journal of Medicinal Chemistry
|
September 27, 2022
Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial <i>Pf</i>GSK3/<i>Pf</i>PK6 with Activity against Blood Stage Parasites In Vitro
Kareem A Galal, Anna Truong, Frank Kwarcinski, et al.
Scientific Reports
|
January 22, 2025
Molecular diversity and genetic potential of new maize inbred lines across varying sowing conditions in arid environment
Ahmed A Galal, Fatmah A Safhi, Nora M Al Aboud, et al.
European Journal of Medicinal Chemistry
|
January 10, 2018
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
Shadia A Galal, Sarah H M Khairat, Hamed I Ali, et al.
European Journal of Medicinal Chemistry
|
April 24, 2017
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs
Shadia A Galal, Ahmed S Abdelsamie, Samia A Shouman, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Archiv Der Pharmazie
|
June 15, 2021
Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor
Sarah H M Khairat, Mohamed A Omar, Fatma A F Ragab, et al.
Reumatologia Clinica
|
June 20, 2021
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters
Abeer M Ghandour, Rania M Gamal, Gehan Seif Eldein, et al.
European Journal of Medicinal Chemistry
|
February 3, 2023
Discovery of potent Plasmodium falciparum protein kinase 6 (PfPK6) inhibitors with a type II inhibitor pharmacophore
Han Wee Ong, Anna Truong, Frank Kwarcinski, et al.
Reumatologia Clinica
|
November 26, 2022
Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters
Abeer M Ghandour, Rania M Gamal, Gehan Seif Eldein, et al.
European Journal of Medicinal Chemistry
|
February 7, 2018
Part III: Novel checkpoint kinase 2 (Chk2) inhibitors; design, synthesis and biological evaluation of pyrimidine-benzimidazole conjugates
Shadia A Galal, Muhammad Khattab, Samia A Shouman, et al.
The Plant Journal : for Cell and Molecular Biology
|
September 25, 2016
Pre-mRNA splicing repression triggers abiotic stress signaling in plants
Yu Ling, Sahar Alshareef, Haroon Butt, et al.
Journal of Medicinal Chemistry
|
September 27, 2022
Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial <i>Pf</i>GSK3/<i>Pf</i>PK6 with Activity against Blood Stage Parasites In Vitro
Kareem A Galal, Anna Truong, Frank Kwarcinski, et al.
Scientific Reports
|
January 22, 2025
Molecular diversity and genetic potential of new maize inbred lines across varying sowing conditions in arid environment
Ahmed A Galal, Fatmah A Safhi, Nora M Al Aboud, et al.
European Journal of Medicinal Chemistry
|
January 10, 2018
Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors
Shadia A Galal, Sarah H M Khairat, Hamed I Ali, et al.
European Journal of Medicinal Chemistry
|
April 24, 2017
Part I: Design, synthesis and biological evaluation of novel pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors with studying their activities alone and in combination with genotoxic drugs
Shadia A Galal, Ahmed S Abdelsamie, Samia A Shouman, et al.
Page
of 14